Telaprevir-based triple therapy for hepatitis C null responders among living donor liver transplant recipients-Reference-Cited by-同舟云学术

Telaprevir-based triple therapy for hepatitis C null responders among living donor liver transplant recipients

Published:2014 Issue:6 Volume:8 Page:339-345
ISSN:1881-7815
Container-title:BioScience Trends
language:en
Short-container-title:BST

Author:

Kaneko Junichi¹,Sugawara Yasuhiko¹,Yamaguchi Takamune¹,Harada Nobuhiro¹,Akamatsu Nobuhisa¹,Ishizawa Takeaki¹,Aoki Taku¹,Sakamoto Yoshihiro¹,Hasegawa Kiyoshi¹,Tamura Sumihito¹,Tanaka Tomohiro²,Kokudo Norihiro¹

Affiliation:

1. Division of Artificial Organ and Transplantation, Department of Surgery, The University of Tokyo

2. Organ Transplantation Service, The University of Tokyo

Publisher

International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine,Health(social science)

Reference21 articles.

1. 1. Akamatsu N, Sugawara Y. Liver transplantation and hepatitis C. Int J Hepatol. 2012; 2012:686135.

2. 2. Ghany MG, Nelson DR, Strader DB, Thomas DL, Seeff LB. An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology. 2011; 54:1433-1444.

3. 3. Werner CR, Egetemeyr DP, Lauer UM, Nadalin S, Konigsrainer A, Malek NP, Berg CP. Telaprevir-based triple therapy in liver transplant patients with hepatitis C virus: a 12-week pilot study providing safety and efficacy data. Liver Transpl. 2012; 18:1464-1470.

4. 4. Reddy KR, Everson GT. Treatment of chronic hepatitis C with protease inhibitor-based therapy after liver transplantation. Hepatology. 2013; 58:1181-1184.

5. 5. Ikegami T, Yoshizumi T, Kato M, Yamamoto S, Fukuhara T, Matsuura Y, Nakamura S, Itoh S, Shirabe K, Maehara Y. Reduced-Dose Telaprevir-Based Triple Antiviral Therapy for Recurrent Hepatitis C After Living Donor Liver Transplantation. Transplantation. 2014.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of simeprevir and sofosbuvir with and without ribavirin in subjects with recurrent genotype 1 hepatitis C postorthotopic liver transplant: the randomized GALAXY study;Transplant International;2017-01-20

2. Research progress on the direct antiviral drugs for hepatitis C virus;BioScience Trends;2017

3. Asunaprevir/daclatasvir and sofosbuvir/ledipasvir for recurrent hepatitis C following living donor liver transplantation;Hepatology Research;2016-12-15

4. An updated systematic review of the evolution of ALPPS and evaluation of its advantages and disadvantages in accordance with current evidence;Medicine;2016-06

5. Is radiofrequency ablation applicable for recurrent hepatocellular carcinoma after liver transplantation?;Journal of Surgical Research;2016-01